Aristea Therapeutics

Aristea Therapeutics, Inc. was founded in 2018 and is headquartered in San Diego, California. It is a clinical-stage drug development startup focused on immunology, primarily developing new therapies for severe inflammatory diseases. The Aristea team has extensive experience in the development and commercialization of novel drugs, with eight drug products approved across a wide range of therapeutic categories, including neuroscience, diabetes/metabolic diseases, inflammation, oncology, and infectious diseases.